QualityStocksNewsBreaks – Bioadaptives Inc (BDPT) Completes Successful Dosage Trials for Zeranovia™ Weight Loss Product
Bioadaptives (BDPT) announced the successful completion of dosage trials for Zeranovia™, its innovative weight loss product. Participants in the trial reported consistent weight loss of 5 to 7 pounds per week with minimal side effects, primarily mild gastrointestinal discomfort that was managed through dosage adjustments. With high participant satisfaction and all subjects eager to continue, BioAdaptives plans to refine dosing for the next phase of clinical trials, reinforcing its commitment to providing effective weight management solutions. To view the full press release, visit https://ibn.fm/Ho0gx About BioAdaptives, Inc. BioAdaptives, Inc. (OTC: BDPT) is a leading innovator in the health and wellness…